Skip to content

Clinical trials

Leukemia, Myeloid, Chronic-Phase trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Chronic-Phase Phase: Not applicable Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20024
20036
20044
20053
20062
20071
20081
20094
20104
20121
20151
20161
20202
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Terminated12
Recruiting2
Unknown status2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center6
Roswell Park Cancer Institute4
University of California, San Francisco4
City of Hope Medical Center3
Wake Forest University Health Sciences3
M.D. Anderson Cancer Center2
Masonic Cancer Center, University of Minnesota2
OHSU Knight Cancer Institute2
Rex Cancer Center, Raleigh, NC2
Asan Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Chronic-Phase45
Precursor Cell Lymphoblastic Leukemia-Lymphoma38
Leukemia, Myeloid, Accelerated Phase37
Burkitt Lymphoma36
Leukemia, Lymphocytic, Chronic, B-Cell35
Lymphoma, Follicular35
Lymphoma, Large B-Cell, Diffuse35
Lymphoma, Large-Cell, Immunoblastic34
Lymphoma, Mantle-Cell34
Lymphoma, Non-Hodgkin34

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.